New data from Eli Lilly says its daily, oral GLP-1 pill may help people who have obesity and people who have Type 2 diabetes ...

The latest results from a trial of a pill form popular GLP-1 medications offer enough information for the Eli Lilly to ...

Under brand names like Ozempic and Wegovy, semaglutide-based medications have made a significant difference in treating type ...

Lilly said it’s moving ‘with urgency toward global regulatory submissions to potentially meet the needs of patients who are waiting.’ ...

A relatively old drug -- metformin -- may hold the key to preventing life-threatening illness and bolstering human longevity, ...

Novo Nordisk said on Monday it is offering its diabetes drug Ozempic for $499 per month to eligible cash-paying type 2 ...

New recommendations suggest holding back on SGLT2 inhibitors and GLP-1s among those at a lower risk for cardiovascular or ...

A recent clinical trial revealed that the new weight loss drug, ecnoglutide, outperformed existing treatment dulaglutide in managing type 2 diabetes and obesity.

Treatment for millions of people with type 2 diabetes should be more personalised, with greater access to newer medicines, ...

When you buy through links on our articles, Future and its syndication partners may earn a commission.